NEU 2.81% $18.65 neuren pharmaceuticals limited

TROFINETIDE TRIALS UPDATE, page-170

  1. 6,080 Posts.
    lightbulb Created with Sketch. 1613
    Piton, may I ask who/what is "the studio"?

    [LittleT maintains that Acadia are analysing their own data (which I find hard to accept) which may speed up the analysis. From my experience, analysis of a major trial has always taken six weeks or more.]
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.